Clinical Trial Update: Sulforaphane as an Antagonist to Human PXR-mediated Drug-drug Interactions [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating sulforaphane as an antagonist of human PXR to mitigate drug-drug interaction effects; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adverse Drug Interactions

Drugs mentioned

• Sulforaphane (sulforaphane)

Snippet

Sponsor: University of Washington | Conditions: Adverse Drug Interactions | Phase 1 | Status: COMPLETED | Results posted: 2019-09-06